Catechol O-methyltransferase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:24, 29 April 2019) (edit) (undo)
 
(15 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='3a7e' size='450' side='right' caption='Structure of human catechol O-methyltransferase complex with SAM and dinitrocatechol (PDB entry [[3a7e]])' scene='55/551215/Cv/1'>
+
<StructureSection load='3a7e' size='350' side='right' caption='Structure of human catechol O-methyltransferase complex with SAM and dinitrocatechol (PDB entry [[3a7e]])' scene='55/551215/Cv/1'>
 +
__TOC__
 +
== Function ==
-
'''Catechol O-methyltransferase''' (COMT) methylates catecholamines like dopamine, epinephrine and norepinephrine. The cofactor S-adenosyl-L-methionine (SAM) serves as the methyl donor in the reaction and is converted to to S-adenosyl-L-homocysteine (SAH) by the reaction. The Parkinson Disease drug levodopa is a substrate of COMT and COMT inhibitors like entacapone are used with levodopa in the disease treatment.
+
'''Catechol O-methyltransferase''' (COMT) methylates catecholamines like dopamine, epinephrine and norepinephrine. The cofactor S-adenosyl-L-methionine (SAM) serves as the methyl donor in the reaction and is converted to to S-adenosyl-L-homocysteine (SAH) by the reaction.<ref>PMID:19111934</ref> For more details see [[Student Projects for UMass Chemistry 423 Spring 2012-6]].
-
== 3D Structures of catechol O-methyltransferase ==
+
== Relevance ==
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
+
The Parkinson Disease drug levodopa is a substrate of COMT and COMT inhibitors like entacapone are used with levodopa in the disease treatment.<ref>PMID:25559423</ref>
-
{{#tree:id=OrganizedByTopic|openlevels=0|
+
-
*Catechol O-methyltransferase
+
==Structural highlights ==
-
**[[2zlb]], [[4p7g]], [[4p7j]] – rCOMT – rat <BR />
+
*<scene name='55/551215/Cv/4'>Active site of human catechol O-methyltransferase complex with SAM and dinitrocatechol</scene> (PDB entry [[3a7e]]). Water molecule is shown as red sphere.
-
**[[4pym]] – rCOMT (mutant) <BR />
+
 
-
**[[4p7f]] – mCOMT - mouse<BR />
+
== 3D Structures of catechol O-methyltransferase ==
-
**[[4pyi]], [[4pyj]], [[4pyk]] – hCOMT – human <BR />
+
[[Catechol O-methyltransferase 3D structures]]
-
*Catechol O-methyltransferase complexes
+
</StructureSection>
-
**[[2zth]] – rCOMT + SAM <BR />
+
== References ==
-
**[[3u81]], [[4pyn]], [[4pyo]] – rCOMT (mutant) + SAH<BR />
+
<references/>
-
**[[4pyq]] – rCOMT (mutant) + ureido-benzamidine<BR />
+
-
**[[1vid]] – rCOMT + SAM + dinitrocatechol <BR />
+
-
**[[1jr4]], [[3hvh]], [[3hvi]], [[3hvj]], [[3hvk]], [[3a7d]], [[3nw9]], [[3nwb]], [[3nwe]] – rCOMT + inhibitor<BR />
+
-
**[[4p7k]], [[4pyl]] – rCOMT + sinefungin<BR />
+
-
**[[3oe4]], [[3oe5]], [[3ozr]], [[3ozs]], [[3ozt]], [[3r6t]] – rCOMT (mutant) + inhibitor<BR />
+
-
**[[1h1d]], [[2cl5]], [[2zvj]], [[3s68]] – rCOMT + inhibitor + SAM<BR />
+
-
**[[2avd]] – hCOMT + SAM – human <BR />
+
-
**[[3bwm]], [[3a7e]] – hCOMT + SAM + dinitrocatechol <BR />
+
-
**[[3bwy]] – hCOMT (mutant) + SAM + dinitrocatechol <BR />
+
-
**[[4p58]] – mCOMT + inhibitor <BR />
+
-
}}
+
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

Structure of human catechol O-methyltransferase complex with SAM and dinitrocatechol (PDB entry 3a7e)

Drag the structure with the mouse to rotate

References

  1. ↑ Tsuji E, Okazaki K, Isaji M, Takeda K. Crystal structures of the Apo and Holo form of rat catechol-O-methyltransferase. J Struct Biol. 2008 Dec 10. PMID:19111934 doi:S1047-8477(08)00293-1
  2. ↑ Muller T. Catechol-O-methyltransferase inhibitors in Parkinson's disease. Drugs. 2015 Feb;75(2):157-74. doi: 10.1007/s40265-014-0343-0. PMID:25559423 doi:http://dx.doi.org/10.1007/s40265-014-0343-0

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Catechol_O-methyltransferase"
Personal tools